The FTSE is lower after a long weekend despite UK factory output rising by the fastest pace in more than six years, albeit from a low level as businesses begin to get back to work.
Movers and shakers include AstraZeneca (LON:AZN) which has received EU approval for Imfinzi which is to treat late stage lung cancer. And the pharma also announced exceptional results for its drug to treat patients with chronic kidney disease.
CentralNic (LON:CNIC) has delivered record growth in the first half despite the global pandemic. The internet domain specialist reported adjusted earnings of US$15.1mln, that up 64% year-on-year.
Kodal Minerals (LON:KOD) is soaring today after an agreement with Chinese engineering firm Sinohydro to work on the company’s lithium project in southern Mali.
And lastly one company that is zooming across the pond is ZOOM! (NASDAQ:ZM) With its stock surging after a 355% boom in quarterly sales. With 370,200 business customers with at least 10 employees - that’s up more than fivefold from a year ago!